Ratings for Stoke Therapeutics (NASDAQ:STOK) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
5
0
0
0
0
Last 30D
1
0
0
0
0
1M Ago
0
0
0
0
0
2M Ago
3
0
0
0
0
3M Ago
1
0
0
0
0
Analysts have set 12-month price targets for Stoke Therapeutics, revealing an average target of $24.2, a high estimate of $35.00, and a low estimate of $20.00. Experiencing a 3.2% decline, the current average is now lower than the previous average price target of $25.00.
Understanding Analyst Ratings: A Comprehensive Breakdown
A clear picture of Stoke Therapeutics's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst
Analyst Firm
Action Taken
Rating
Current Price Target
Prior Price Target
Joseph Stringer
Needham
Maintains
Buy
$22.00
$22.00
Andrew Fein
HC Wainwright & Co.
Maintains
Buy
$35.00
$35.00
Sumant Kulkarni
Canaccord Genuity
Lowers
Buy
$20.00
$21.00
Joseph Stringer
Needham
Maintains
Buy
$22.00
$22.00
Joseph Stringer
Needham
Maintains
Buy
$22.00
-
Key Insights:
Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their ...Full story available on Benzinga.com
Benzinga
